Home/Filings/4/0001493152-26-000854
4//SEC Filing

Litten Jason 4

Accession 0001493152-26-000854

CIK 0001231457other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 5:32 PM ET

Size

5.5 KB

Accession

0001493152-26-000854

Insider Transaction Report

Form 4
Period: 2026-01-02
Litten Jason
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-02+275,000275,000 total
    Exercise: $4.55Exp: 2036-01-01Common Stock (275,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 36 equal monthly installments thereafter.

Documents

1 file

Issuer

GENELUX Corp

CIK 0001231457

Entity typeother

Related Parties

1
  • filerCIK 0001909400

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:32 PM ET
Size
5.5 KB